v3.24.0.1
Consolidated Statement Of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES      
Net income (loss) including noncontrolling interests $ 37,354 $ 57,577 $ 23,598
Adjustments for noncash transactions      
Depreciation and depletion (includes impairments) 20,641 24,040 20,607
Deferred income tax charges/(credits) 634 3,758 303
Postretirement benefits expense in excess of/(less than) net payments 90 (2,981) 754
Other long-term obligation provisions in excess of/(less than) payments (1,501) (1,932) 50
Dividends received greater than/(less than) equity in current earnings of equity companies 509 (2,446) (668)
Changes in operational working capital, excluding cash and debt      
Notes and accounts receivable reduction/(increase) 4,370 (11,019) (12,098)
Inventories reduction/(increase) (3,472) (6,947) (489)
Other current assets reduction/(increase) (426) (688) (71)
Accounts and other payables increase/(reduction) (4,727) 18,460 16,820
Net (gain)/loss on asset sales (513) (1,034) (1,207)
All other items - net 2,410 9 530
Net cash provided by operating activities 55,369 76,797 48,129
CASH FLOWS FROM INVESTING ACTIVITIES      
Additions to property, plant and equipment (21,919) (18,407) (12,076)
Proceeds from asset sales and returns of investments 4,078 5,247 3,176
Additional investments and advances (2,995) (3,090) (2,817)
Other investing activities including collection of advances 1,562 1,508 1,482
Net cash used in investing activities (19,274) (14,742) (10,235)
CASH FLOWS FROM FINANCING ACTIVITIES      
Additions to long-term debt 939 [1] 637 46
Reductions in long-term debt (15) (5) (8)
Additions to short-term debt 0 198 12,687
Reductions in short-term debt (879) (8,075) (29,396)
Additions/(reductions) in debt with three months or less maturity (284) 25 (2,983)
Contingent consideration payments (68) (58) (30)
Cash dividends to ExxonMobil shareholders (14,941) (14,939) (14,924)
Cash dividends to noncontrolling interests (531) (267) (224)
Changes in noncontrolling interests (770) (1,475) (436)
Common stock acquired (17,748) (15,155) (155)
Net cash provided by (used in) financing activities (34,297) (39,114) (35,423)
Effects of exchange rate changes on cash 105 (78) (33)
Increase/(decrease) in cash and cash equivalents 1,903 22,863 2,438
Cash and cash equivalents at beginning of year 29,665 6,802 4,364
Cash and cash equivalents at end of year $ 31,568 $ 29,665 $ 6,802
[1]
 Includes $568 million issued to facilitate the sale of an entity where the buyer assumed the debt upon closing; no longer on the Consolidated Balance Sheet at the end of 2023.

Source